Christoph Winkler and Dr. Kelvin See, National University of Singapore (IMAGE)

National University of Singapore

Christoph Winkler and Dr. Kelvin See, National University of Singapore

Caption

A research team led by Assoc Prof Christoph Winkler (right) and Dr Kelvin See (left) identified Neurexin2 as a novel target for potential therapy of neurodegeneration in Spinal Muscular Atrophy patients.

Credit

Yu Tingsheng

Usage Restrictions

To add in image credit

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.